Off-the-shelf treatments for cancer made from genetically engineered T cells and natural killer, or NK, cells have each shown promise in clinical trials. On
Tag - biotechnology
Dyno Therapeutics, a Cambridge biotech that uses artificial intelligence techniques to develop gene therapies, said Thursday that it has raised $100 million
Sarepta Therapeutics said Monday that a second-generation medicine for patients with a certain type of Duchenne muscular dystrophy showed improved performance
Thermo Fisher Scientific announced Thursday that it will buy PPD, a contract-research company for the pharmaceutical and biotech industries, in a deal valued
A panel of expert advisers to the Food and Drug Administration on Thursday concluded that the risks of an investigational pain treatment from Pfizer might
The Broad Institute of MIT and Harvard is launching a new, $300 million initiative that applies advanced computer science to some of the hardest problems in
Federal authorities on Thursday charged two co-founders of uBiome, a microbiome startup that rose to Silicon Valley prominence in 2018, with defrauding
The Food and Drug Administration on Thursday approved a new medicine from Sarepta Therapeutics that treats certain patients with Duchenne muscular dystrophy
Amicus Therapeutics said Thursday that its drug for patients with Pompe disease, a rare genetic condition, failed to demonstrate superiority over the current
A drug from Amgen designed to block the cancer protein known as KRAS shrank tumors in 37% of patients with advanced lung cancer and delayed tumor progression
